GB1080599A - Improvements in and relating to l-ornithine l-aspartate - Google Patents

Improvements in and relating to l-ornithine l-aspartate

Info

Publication number
GB1080599A
GB1080599A GB50695/63A GB5069563A GB1080599A GB 1080599 A GB1080599 A GB 1080599A GB 50695/63 A GB50695/63 A GB 50695/63A GB 5069563 A GB5069563 A GB 5069563A GB 1080599 A GB1080599 A GB 1080599A
Authority
GB
United Kingdom
Prior art keywords
ornithine
aspartate
salt
type
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB50695/63A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of GB1080599A publication Critical patent/GB1080599A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB50695/63A 1962-12-27 1963-12-23 Improvements in and relating to l-ornithine l-aspartate Expired GB1080599A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
GB1080599A true GB1080599A (en) 1967-08-23

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
GB50695/63A Expired GB1080599A (en) 1962-12-27 1963-12-23 Improvements in and relating to l-ornithine l-aspartate

Country Status (5)

Country Link
BE (1) BE641880A (es)
FR (1) FR3150M (es)
GB (1) GB1080599A (es)
LU (1) LU45106A1 (es)
NL (1) NL302572A (es)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447366A (en) * 1980-12-04 1984-05-08 Morelle Jean V Derivatives of lysine and aspartic acid
US8173706B2 (en) 2009-04-03 2012-05-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US8389576B2 (en) 2004-11-26 2013-03-05 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US8946473B2 (en) 2010-10-06 2015-02-03 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
US10039735B2 (en) 2014-11-24 2018-08-07 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
US11266620B2 (en) 2009-06-08 2022-03-08 Ucl Business Ltd Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447366A (en) * 1980-12-04 1984-05-08 Morelle Jean V Derivatives of lysine and aspartic acid
US9566257B2 (en) 2004-11-26 2017-02-14 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US10610506B2 (en) 2004-11-26 2020-04-07 Ucl Business Ltd Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US8389576B2 (en) 2004-11-26 2013-03-05 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US9034925B2 (en) 2009-04-03 2015-05-19 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US11161802B2 (en) 2009-04-03 2021-11-02 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US8785498B2 (en) 2009-04-03 2014-07-22 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US9604909B2 (en) 2009-04-03 2017-03-28 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US8492439B2 (en) 2009-04-03 2013-07-23 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US10173964B2 (en) 2009-04-03 2019-01-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US10550069B2 (en) 2009-04-03 2020-02-04 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US8173706B2 (en) 2009-04-03 2012-05-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US11266620B2 (en) 2009-06-08 2022-03-08 Ucl Business Ltd Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
US8946473B2 (en) 2010-10-06 2015-02-03 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
US9260379B2 (en) 2010-10-06 2016-02-16 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
US10039735B2 (en) 2014-11-24 2018-08-07 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US11040021B2 (en) 2014-11-24 2021-06-22 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10525029B2 (en) 2014-11-24 2020-01-07 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate

Also Published As

Publication number Publication date
LU45106A1 (es) 1964-02-24
BE641880A (es) 1964-04-16
FR3150M (fr) 1965-02-22
NL302572A (es)

Similar Documents

Publication Publication Date Title
GB1080599A (en) Improvements in and relating to l-ornithine l-aspartate
GB1090779A (en) Substituted alkane sulphonic acids and derivatives thereof
ES366470A1 (es) Un procedimiento para la preparacion de pirazinoilgunidinasy pirazinomidoguanidinas.
GB1232764A (es)
GB921874A (es)
GB860910A (en) Purification of halogenated salicylanilides
GB1165204A (en) Multiple Unsaturated Aliphatic Compounds
GB910991A (en) 5-methoxy-ª--ethyl tryptamine
GB1090359A (en) New adenosine-ketals
ES335892A1 (es) Procedimiento para la preparacion de nitrocolorantes de la serie adridonica.
GB1157393A (en) Process for the Preparation of Aminoacetic Acid
ES294862A1 (es) Procedimiento para preparar l-ornitina l-aspartato
GB964452A (es)
GB1144968A (en) Improvements in or relating to the preparation of cyclohexylsulfamic acid
GB1162052A (en) Process for the Preparation of gamma-Methylmercapto-alpha-Aminobutyronitrile and its Conversion to Methionine
GB958866A (en) Production of ethylene sulphide
GB1054148A (es)
GB692968A (en) Process for the manufacture of stable preparations of vitamins of the b group
GB975722A (en) A process for producing ª‰-amino-ª†-hydroxybutyric acid
GB1305486A (es)
GB1048867A (en) Process for the production of anhydrous salt of fumaric acid with divalent iron
GB841735A (en) Improvements in herbicidal compositions
FR2067844A5 (en) Lithium dialuminium heptahydride prepn
AU259672B2 (en) Vaporization of adipic acid and reaction thereof with ammonia to produce adiponitrile
GB1025058A (en) Process for the production of 1-methylcyclohexene-(1)